Fraudulent Science: What’s Retracted, What’s Not

17retraction-graphic-nyt.png

Even if retracted, published clinical trial reports that misrepresent findings, withhold negative data, or make false, or unsubstantiated claims have done irreparable damage. AHRP calls upon all medical journals to adopt a publication policy requiring submission of the sponsor’s formal Clinical Study Report to accompany articles about clinical trial findings. 

Continue reading →

Fraudulent Science: What’s Retracted, What Is Not

 Even as the corruption of science is no longer a dirty little secret, but is in plain sight, no one is doing anything tostop it.    April 16, 2012 A Sharp Rise in Retractions Prompts Calls for Reform By CARL ZIMMER In . . . Continue reading →

Psychiatry Texbook Penned by Two Academic Leaders –GSK Ghosted

“To ghostwrite an entire textbook is a new level of chutzpah,” said Dr. David A. Kessler, former commissioner of the Food and Drug Administration, after reviewing the documents. “I’ve never heard of that before. It takes your breath away.” Continue reading →

Is FDA Bipolar or Complicit in Legitimizing Illegal Marketing?

The FDA’s expanded marketing approval process for antipsychotics, highly toxic drugs, is unaffected by evidence uncovered by the US Justice Department showing that the studies submitted by drug manufacturers were often flawed, if not fraudulent. Continue reading →

Senator Grassley Might Leave Finance Committee: A Break For Pharma?

The Hill , a newspaper covering congressional news, reports: "Sen. Chuck Grassley (Iowa) is considering leaving his powerful post as senior Republican on the Finance Committee so that he can become the highest-ranking Republican on the Judiciary panel. To avoid a dramatic . . . Continue reading →

Psychiatrists On the Take: the Focus of Government Investigations

Two prominent academic-psychiatrists–Jeffrey Bostic MD, director of school psychiatry, Harvard-Massachusetts General Hospital, and Charles Nemeroff MD, the former chairman of psychiatry at Emory–are featured in current government investigations.
Continue reading →

Marcia Angell: Drug Co & Doctors: A Story of Corruption

"It is simply no longer possible to believe much of the clinical research that is published, or to rely on the judgment of trusted physicians or authoritative medical guidelines. I take no pleasure in this conclusion, which I reached slowly and reluctantly over my two decades as an editor of The New England Journal of Medicine." Marcia Angell, MD Continue reading →